Sub Heading

Clinical Trials Details

Randomized phase II/III trial of radiation with high-does Cisplatin (100 mg/m²) every three weeks versus radiation with low-does weekly Cisplatin (40 mg/m²) for patients with locoregionally advanced squamous cell carcinoma of the head and neck.

IRB Protocol Number
NRG HN009

Clinical Trial Categories

  • Head and Neck
Contact
Clinical Trials at 910-715-2200
How to Participate

Eligibility: Men or women age 18 and older with squamous cell cancer of the head and neck without distant metastasis.

Contact Us

For more information on participating in a clinical trial, contact us at 910-715-2200 or talk to your doctor.